March 2008 Volume 4, Issue 3

Volume 4, Issue 3 | March 2008

March 2008

In this Issue

Global News

Drug Discovery News Placeholder Image

Wyeth sharpens axe

Job cuts could total 10 percent of workforce, or 5,000 jobs
Drug Discovery News Placeholder Image

Mergin' derma for $421M

CollaGenex agrees to cross-Atlantic takeover by Galderma
Drug Discovery News Placeholder Image

Going global

New study of breast cancer therapies could be a model for global clinical trials

Informatics

Drug Discovery News Placeholder Image

Clinically correct behavior

Surveillance Data Inc. acquires trialytics to deliver improved data-driven clinical trial development services
Drug Discovery News Placeholder Image

Found in translation

InforSense launches packaged translational research solution, with Erasmus Medical Center among first to put it to the test
Drug Discovery News Placeholder Image

GeneGo tapped for tox project

The Netherlands Toxicogenomics Centre lands $100M to develop better tox data

Research & Development

Drug Discovery News Placeholder Image

Invisibly small stands tall

Scientists at UCLA, Northwestern use nanomaterials to localize, control drug delivery
Drug Discovery News Placeholder Image

Hitting targets one cell at a time

Stem Cell Sciences, Myelin to develop cell sources
Drug Discovery News Placeholder Image

Scientists ganging up on hepatitis C

Presidio, Numerate take the wraps off research collaboration to identify therapeutics

Automation & Instrumentation

Drug Discovery News Placeholder Image

Across the board

InNexus files patent applications that set the stage for its DXL platform to move into diagnostics

Genomics & Proteomics

Drug Discovery News Placeholder Image

UNC going into overdrive

Discovery of “overdrive” GPCRs that function within cells may broaden drug design options
Drug Discovery News Placeholder Image

A fine molecular pairing

Qiagen and Center for Molecular Medicine form research collaboration
Drug Discovery News Placeholder Image

‘Jekyll and Hyde’ gene?

STAT3 can both encourage or stifle cancer growth
Drug Discovery News Placeholder Image

Something for more refined tastes

Genedata gets another high-profile placement of Expressionist technology with Roche
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.
Stem cells are shown as clear, purple, and blue spheres against a dark blue and black background.
Human-relevant, ready-to-use stem cell models are reshaping drug discovery, toxicity testing, and personalized medicine.
Characterizing lipid nanoparticles for RNA therapeutic development
Integrated multiomics and advanced nanoparticle analytics are improving how researchers perform RNA delivery, increasing therapeutic success.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue